Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Biomaterials. 2009 Nov 14;31(7):1944. doi: 10.1016/j.biomaterials.2009.10.060

Fig. 6.

Fig. 6

Release of GPRP-FnIII9-10 versus GSPE-FnIII9-10 from thrombin- or batroxobin-catalyzed fibrin clots. Clot compositions as described in Fig. 5. 200 μL clots were overlaid with 1 mL Tris+Ca buffer and samples were taken at the designated timepoints over 4 days. (A, B) GPRP/GSPE-FnIII9-10-biotin measured in the samples taken from thrombin-catalyzed clots and the compiled release profiles. (C, D) Corresponding data from clots formed in the presence of batroxobin.